Menu Close

Trending

Bayer grabs Chinese okay for CKD therapy Kerendia
Novartis eyes earlier use of PD-1 drug in oesophageal cancer
A 3-step guide to addressing difficult issues and creating mutual solutions
AZ takes aim at BMS’ lead in neoadjuvant NSCLC
Blueprint cashes in on the past to build its future

anxiety disorders

Synendos_therapeutics

News/ News/ R&D

Switzerland’s Synendos raises CHF 20m for CNS drug development

, , , , 0 Comment

Swiss startup Synendos Therapeutics has raised CHF 20 million (almost $22 million) in first-round financing that will be

X
Switzerland’s Synendos raises CHF 20m for CNS drug development
https://pharmaphorum.com/news/embargo-8am-gmt-12-nov-switzerlands-synendos-raises-chf-20m-for-cns-drug-development/

Login

CONTINUE TO SITE >
X
Close in 10 seconds